Insider Trading April 1, 2026

Ridgepost Capital Director Purchases $50,890 of RPC Shares as Company Finalizes Rebrand

Director Robert B. Stewart Jr. adds to his stake while the stock trades near its 52-week low; company moves forward with a name change, Dubai expansion and a GP-stakes partnership

By Nina Shah RPC
Ridgepost Capital Director Purchases $50,890 of RPC Shares as Company Finalizes Rebrand
RPC

Robert B. Stewart Jr., a director at Ridgepost Capital, Inc., purchased 7,000 Class A shares on March 31, 2026, spending $50,890 at $7.27 per share. The trade comes as the shares trade close to a 52-week low and follows a corporate rebrand from P10 to Ridgepost Capital, Inc., effective February 11, 2026. The firm has also opened an office in the Dubai International Financial Centre and, through Bonaccord Capital Partners, entered a distribution arrangement with CAIS to broaden access to GP stakes solutions for financial advisors.

Key Points

  • Director Robert B. Stewart Jr. bought 7,000 Class A shares on March 31, 2026, at $7.27 per share, totaling $50,890.
  • The company completed a rebrand from P10, Inc. to Ridgepost Capital, Inc., effective February 11, 2026, and trades under the RPC ticker on NYSE and NYSE Texas.
  • Ridgepost expanded its international presence with a licensed office in the Dubai International Financial Centre and, via Bonaccord Capital Partners, partnered with CAIS to broaden access to GP stakes for financial advisors - sectors impacted include financial services and wealth management.

Robert B. Stewart Jr., a member of the board at Ridgepost Capital, Inc. (EXCHANGE:RPC), completed a direct purchase of 7,000 Class A Common Stock shares on March 31, 2026. The trade was executed at $7.27 per share, resulting in a cash outlay of $50,890.

At the time of the transaction, the company’s shares were trading close to their 52-week low of $6.85, and had declined 31.5% over the previous six months. Following the acquisition, Stewart holds 156,525 shares of Ridgepost Capital on a direct basis.

Valuation notes and investor resources

According to InvestingPro analysis cited in company reporting, the stock appears undervalued at current prices. The report references additional paid content available through the platform, noting there are nine extra ProTips and a comprehensive Pro Research Report covering RPC for subscribers seeking a deeper assessment.

Corporate identity and strategic moves

Separately, the company finalized a corporate name change. P10, Inc. is now Ridgepost Capital, Inc., effective February 11, 2026, and the firm began trading under the new ticker symbol "RPC" on both the New York Stock Exchange and NYSE Texas. Company communications state the rebrand is intended to reflect a focus on "stability, perspective, and protection."

As part of its international expansion, the company opened an office in the Dubai International Financial Centre that operates under a license from the Dubai Financial Services Authority. Management described the move as an effort to strengthen client partnerships across the Middle East.

Distribution partnership and product access

Through its Bonaccord Capital Partners subsidiary, P10 has entered into a partnership with CAIS aimed at giving financial advisors enhanced access to GP stakes solutions. The partnership will utilize CAIS’s distribution platform, which the company reports serves over 2,000 wealth management firms and 62,000 financial advisors. The collaboration is presented as part of the company’s effort to broaden its market reach and service set.

What this means for investors

The insider purchase updates Stewart’s direct holding and comes amid company-level changes that include a rebrand, geographic expansion and a distribution tie-up intended to increase advisor access to certain alternative investment strategies. Additional research and valuation tools referenced in the company materials are available through the InvestingPro service for those seeking further analysis.

Risks

  • Share price volatility - RPC shares were trading near a 52-week low and are down 31.5% over six months, indicating market price risk for equity investors.
  • Execution risk related to corporate changes - the effectiveness of the rebrand, the Dubai expansion and the CAIS partnership in delivering expected benefits is not assured.
  • Valuation uncertainty - the InvestingPro analysis cited indicates the stock "appears undervalued," but this assessment and related premium research access are available through a paid platform, which may limit transparency for all investors.

More from Insider Trading

Gevo COO Sells 129,797 Shares as Company Posts Strong Revenue Gain but Remains Unprofitable Apr 1, 2026 Dianthus Therapeutics Director Disposes of $47,985 in Shares, Exercises Options Apr 1, 2026 Dianthus CFO Sells $9.5M in Stock as Company Completes $719M Offering Apr 1, 2026 Processa Pharmaceuticals R&D President Buys 1,810 PCSA Shares; Company Reports Phase 2 Dosing Complete Apr 1, 2026 Processa Pharmaceuticals director buys $5,252 of PCSA stock, increases direct holding Apr 1, 2026